Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Biological age & clocks
Research brief

Sex-specific nonlinear immune aging in 1,828 healthy people's blood cells

In a single-cell transcriptome of 3.8 million blood cells from 1,828 healthy people aged 19–97, immune aging appeared nonlinear, with gene-expression peaks around age 40 and after 60 and sex-dependent kinetics; sex-stratified biological age clocks outperformed sex-combined models. [1]

Automatic summary · not editorially reviewed

The key findings

  1. The analysis covered 3.8 million PBMCs from 1,828 individuals aged 19–97 years in a multi-ethnic single-cell transcriptome, 35% Asian. [1]

  2. Differential gene expression peaked around age 40 mainly in CD4 T cells and after age 60 mainly in CD8 T cells. [1]

  3. Sex-stratified deep learning biological age clocks outperformed sex-combined models, and the authors propose targeting sex-specific pathways for precision geromedicine. [1]

The source at a glance

Study type / format
Single-cell transcriptome analysis of healthy human immune aging (abstract)
Population / context
1,828 healthy individuals aged 19–97 years, 35% Asian, whose PBMCs were analyzed.
Summary based on
Study abstract
Original publication
August 21, 2026

Single-cell blood atlas of 1,828 healthy people

The authors analyzed a multi-ethnic single-cell transcriptome of healthy human immune aging, 35% Asian, comprising 3.8 million peripheral blood mononuclear cells (PBMCs) from 1,828 individuals aged 19–97 years. This describes the measured population and material; the abstract does not report how participants were recruited or how many cells came from each person.

Supporting source [1]

Expression peaks near 40 and after 60 years

Prominent peaks of differential gene expression occurred around age 40, mainly in CD4 T cells, and after age 60, mainly in CD8 T cells. These peaks were accompanied by an age-dependent decline in RNA/protein homeostasis and by inflammatory PBMC polarization with sex-dependent kinetics. Females showed sustained CD8 T cell activation and late-life aging signatures in CD4 T, natural killer (NK) and B cells; males showed early-life fluctuations in CD4 T cell immunometabolism associated with hypomethylation of SSH3 at chromosome 11q13.

Supporting source [1]

Sex-stratified clocks and proposed precision geromedicine

Deep learning-based biological age clocks stratified for sex outperformed sex-combined models, learning from transcriptional immune trajectories. The authors describe a nonlinear PBMC aging pattern and suggest that targeting sex-specific pathways might allow precision geromedicine. This is a proposed direction, not a validated intervention; the abstract reports no health or lifespan outcomes and no test of such targeting.

Supporting source [1]

How to interpret this

Abstract only; the full text was not reviewed. The abstract reports no recruitment details, no health or lifespan outcomes and no test of targeting sex-specific pathways; the geromedicine idea is a proposal, and observed associations are not causes.

Based on the study abstract; the full paper, tables and supplementary data were not reviewed.

Source & supporting passages

[1]
Sex-specific trajectories of nonlinear immune aging at single-cell level.

Park H, Le Bert N, Bertoletti A, Tolwinski N, Gruber J, Behmoaras J. · europepmc.org · August 21, 2026

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    3.8 million peripheral blood mononuclear cells
  2. Finding 2 ↑

    peaks of differential gene expression around 40
  3. Finding 3 ↑

    biological age clocks stratified for sex outperformed

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…